Oncology Portfolio Communications

Oncology Portfolio Communications & Public Affairs Leader Join to apply for the Oncology Portfolio Communications & Public Affairs Leader role at Johnson & Johnson Innovative Medicine. Overall Purpose Of The Role As the EMEA Oncology Portfolio Communications & Public Affairs Leader at Johnson & Johnson Innovative Medicine (IM), you will be responsible for advancing, protecting, and enhancing the company’s portfolio visibility and reputation, and strengthening patient advocacy in Oncology Solid Tumours and Precision Medicine across the Europe, Middle East, and Africa (EMEA) region. In this position you will shape the strategy and positioning of the Oncology business across EMEA in close collaboration with functions including Commercial Strategy, Regulatory, Market Access, Medical Affairs and Marketing, as well as Communications & Public Affairs (CPA) and Patient Engagement & Advocacy (PEA) teams at a local, regional and global level. You will manage and oversee end‑to‑end pipeline and product CPA and patient advocacy activities, including media, social media, congress communications, thought leadership, internal communications activities, and product issues management across EMEA markets, as well as leading regional patient advocacy and engagement initiatives. Elevate external alliances and strengthen the public affairs lens by creating and deploying strategic third‑party advocacy with payers, policymakers and patient groups to accelerate access to key pipeline assets. You will report to the EMEA Access, Portfolio Communications & Public Affairs (APCPA) Leader. Key Responsibilities And Impact Lead Oncology Solid Tumours Portfolio CPA in EMEA: Design and execute EMEA‑specific, insights‑driven CPA strategies in support of J&J’s Oncology Solid Tumors Therapeutic Area (TA) priorities and market needs, spanning in‑market and pipeline products and indications, including lung cancer, bladder cancer, prostate cancer, colorectal cancer and head & neck cancer. Develop/adapt and implement J&J’s Oncology TA and Precision Medicine positioning, narrative and messaging in EMEA. Lead pre‑launch, launch and post‑launch in‑market communications, data and regulatory milestones communications and public affairs, through integrated, multi‑channel communications plans (media, social/digital, congress, etc.) Represent EMEA Operating Companies’ voice in J&J Global Oncology forums and strategic planning processes, ensuring feedback and alignment. Lead Oncology Solid Tumours Portfolio Patient Advocacy & Public Affairs in EMEA: Serve as single point of contact (SPOC) for regional Patient Advocacy Groups in oncology solid tumour indications, leading and shaping short‑ to long‑term support and partnership activities in collaboration with the EMEA Patient Engagement & Advocacy (PE&A) team. Develop disease‑specific strategies to enhance access across key therapeutic areas, collaborating with Patient Engagement & Advocacy, Public Affairs and Government Affairs & Policy teams. Lead the development of co‑created advocacy activities such as disease awareness campaigns, patient and caregiver educational initiatives, etc. Drive external alliance‑building and third‑party advocacy to secure faster patient access to key pipeline assets. Continuously identify and recruit payer, policymaker and patient advocacy partners; co‑design advocacy asks and multi‑channel campaigns; orchestrate stakeholder engagement and external communications; and translate stakeholder intelligence into targeted policy and reimbursement interventions. Oversee Oncology Solid Tumours and Precision Medicine Business & Leadership Communication: Oversee Thought Leadership activities to position J&J as a Pharma leader in Oncology and Precision Medicine in alignment with the EMEA Business & Leadership Communications team, and respective Oncology and Precision Medicine leaders. Oversee relevant strategic internal communications activities in support of critical business priorities, including major product regulatory milestones, HTA and clinical trial developments. Co‑lead EMEA execution of joint flagship campaigns in Oncology & Haematology: Partner with the Haematology CPA Lead to develop and execute comprehensive Oncology‑wide communication strategies (e.g. In Front of Cancer campaign) that resonate with the EMEA region while aligning with global campaign objectives. Identify and leverage opportunities for storytelling that showcase our commitment to cancer care and treatment innovations, elevating our brand’s presence within the oncology community. Lead the creation of compelling content across various channels, including social media, press releases, and internal communications, ensuring messages are impactful and aligned with our campaign goals. Develop Oncology PCPA and PEA Capabilities and Community in EMEA: Shape and co‑lead the EMEA Oncology Portfolio Communications & Public Affairs (PCPA) community to promote strategy consistency and effectiveness across markets and ensure markets’ needs are considered in everything we need. Establish and continuously improve PCPA and patient advocacy capabilities across the region, ensuring alignment with global and regional standards and best practices. Contribute to the development and implementation of regional playbooks, messaging, toolkits, trainings, and materials tailored for local Operating Companies’ needs. Lead Research and Insights: Generate and leverage key insights from audience research to continuously refine and improve impact of PCPA and PEA strategies in Oncology. Monitor and analyze industry and reputational trends and competitive benchmarks to drive competitiveness. Implement and track standardized metrics (KPIs) aligned with global CPA and EMEA CPA Measurement Framework to monitor performance and refine strategies. Lead Issues Communications and Crisis Management: Provide strategic counsel and lead coordination of local or regional Oncology Solid Tumours product‑related issues and crisis communications, ensuring timely responses to reputation risks in collaboration with EMEA Reputation Lead, global and local teams. Leadership Responsibilities: Lead, coach and develop the EMEA Oncology solid tumours CPA PEA team as part of the regional APCPA team – 1 direct report. Opportunity to co‑lead the EMEA Oncology PCPA Community with 25‑30 people (rotating co‑leadership), facilitating priority setting and cross‑functional work through the community of practice and squads. Collaborate with EMEA Haematology CPA and PEA leads on cross‑Oncology TA planning and initiatives. As a member of the EMEA PCPA Team, lead initiatives supporting key therapeutic areas priorities. Represent the Communications & Public Affairs (CPA) and Patient Engagement & Advocacy (PEA) function within key internal business groups and committees. Key Requirements Experience: At least 10 years of experience in product and portfolio communications, public affairs, patient and/or a similar role within the pharmaceutical or healthcare industry. Proven success in launching innovative medicines in EMEA, media relations, digital strategy, congresses, and crisis management at a senior level. Experience in early market shaping is desirable. Strong leadership and excellent interpersonal skills, capable of operating at senior level with high strategic thinking, creating and maintaining relationships with a variety of stakeholders and mobilizing teams around ambitious and innovative projects. Experience in leading, mentoring, and developing direct reports preferred, with expertise in managing cross‑functional collaboration within matrixed organizations. Skills & Competencies: Strong leadership and strategic thinking abilities, with experience building relationships with senior stakeholders across multiple markets. Experience and/or interest in leading transformation and agile ways of working. Exceptional written and verbal communication skills. In‑depth understanding of media, digital, social media and AI platforms. Ability to thrive in a fast evolving and complex environment, balancing multiple priorities while aligning with business goals. University degree in Sciences, Medical, or Communications, or a related field. A Master’s degree is preferred. Fluency in English; additional language skills in EMEA are a plus. Additional Information: This role requires travel across the EMEA region as needed. Preferred Skills: Brand Reputation Management, Communications Measurement, Corporate Communications Management, Corporate Communications Strategy, Corporate Management, Cultural Competence, Developing Others, External Communication, Inclusive Leadership, Leadership, Media Relations, Organizational Knowledge, Quality Assurance (QA), Relationship Building, Social Awareness, Stakeholder Engagement, Strategic Thinking, Team Management. #J-18808-Ljbffr